ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Chlorotrimethylsilane → 1-(4-Hydroxy-4-(pyridin-3-yl)piperidin-1-yl)-2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)pyrrolidin-2-yl)methoxy)ethanone hydrochloride

HRID 2041090
印刷

反応式

HRID 2041090 の反応式
COC1C=C(C)C(S(N2CCCC2COCC(O)=O)(=O)=O)=C(C)C=1.N1C=CC=C(C2(O)CCNCC2)C=1.C(=O)(O)[O-].[Na+].[OH:43][C:44]1([C:73]2[CH:74]=[N:75][CH:76]=[CH:77][CH:78]=2)[CH2:49][CH2:48][N:47]([C:50](=[O:72])[CH2:51][O:52][CH2:53][CH:54]2[CH2:58][CH2:57][CH2:56][N:55]2[S:59]([C:62]2[C:67]([CH3:68])=[CH:66][C:65]([O:69][CH3:70])=[CH:64][C:63]=2[CH3:71])(=[O:61])=[O:60])[CH2:46][CH2:45]1.[Cl:79][Si](C)(C)C>C(Cl)Cl.C(C(C)=O)C.C(OCC)C.C(OCC)C>[ClH:79].[OH:43][C:44]1([C:73]2[CH:74]=[N:75][CH:76]=[CH:77][CH:78]=2)[CH2:45][CH2:46][N:47]([C:50](=[O:72])[CH2:51][O:52][CH2:53][CH:54]2[CH2:58][CH2:57][CH2:56][N:55]2[S:59]([C:62]2[C:67]([CH3:68])=[CH:66][C:65]([O:69][CH3:70])=[CH:64][C:63]=2[CH3:71])(=[O:60])=[O:61])[CH2:48][CH2:49]1
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 5

HCID 6397ChlorotrimethylsilaneHCID 516892Sodium BicarbonateHCID 49891674-(Pyridin-3-yl)piperidin-4-olHCID 597464542-((1-(4-Methoxy-2,6-dimethylphenylsulfonyl)pyrrolidin-2-yl)methoxy)acetic acidHCID 598200831-(4-Hydroxy-4-(pyridin-3-yl)piperidin-1-yl)-2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)pyrrolidin-2-yl)methoxy)ethanone

生成物 1

HCID 69324303
1-(4-Hydroxy-4-(pyridin-3-yl)piperidin-1-yl)-2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)pyrrolidin-2-yl)methoxy)ethanone hydrochloride

試薬・触媒・溶媒 3

HCID 3283Diethyl Ether溶媒HCID 6344Dichloromethane溶媒2 回HCID 19800284Diethyl ether 2-butanone溶媒

実験手順

N,N′-Carbonyldiimidazole (71 mg, 0.441 mmol) was added to a solution of 2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)pyrrolidin-2-yl)methoxy)acetic acid (acid unit S27) (150 mg, 0.420 mmol) in methylene chloride (7 ml) and the mixture was stirred for 1 h at room temperature. A solution of 4-(pyridin-3-yl)piperidin-4-ol (A2) (74 mg, 0.420 mmol) in methylene chloride (3 ml) was subsequently added and the reaction mixture was stirred for 15 h at room temperature. Thereafter, saturated sodium bicarbonate solution (10 ml) was added to the reaction mixture and the aqueous phase was subsequently extracted with methylene chloride (2×10 ml). The combined organic phases were extracted with saturated sodium chloride solution (10 ml), dried with sodium sulfate and concentrated in vacuo. The crude product was purified by flash chromatography with ethyl acetate/methanol/hexane (10:1:1). 1-(4-Hydroxy-4-(pyridin-3-yl)piperidin-1-yl)-2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)pyrrolidin-2-yl)methoxy)ethanone (160 mg, 0.309 mmol) was dissolved in methyl ethyl ketone/diethyl ether (1:1; 5 ml), and chlorotrimethylsilane (59 μl, 0.464 mmol) was slowly added. Diethyl ether (10 ml) was subsequently added and the mixture was stirred for 1 h at 0° C. The precipitate formed was filtered off, dried with exclusion of air and washed with diethyl ether.

後処理

  1. stirringthe reaction mixture was stirred for 15 h at room temperature
  2. extractionthe aqueous phase was subsequently extracted with methylene chloride (2×10 ml)
  3. extractionThe combined organic phases were extracted with saturated sodium chloride solution (10 ml)
  4. dry with materialdried with sodium sulfate
  5. concentrationconcentrated in vacuo
  6. customThe crude product was purified by flash chromatography with ethyl acetate/methanol/hexane (10:1:1)
  7. stirringthe mixture was stirred for 1 h at 0° C
  8. customThe precipitate formed
  9. filtrationwas filtered off
  10. customdried with exclusion of air
  11. washwashed with diethyl ether

出典と根拠

ORDレコード
ord-cd777d83155743dc9e78cef61412562d
出典データセット
uspto-grants-2013_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08580965B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート